MT. LAUREL, New Jersey, June 19 -- The American Society of Transplantation issued the following news:

Critical Path Institute(C-Path) announced that its Transplant Therapeutics Consortium (TTC) has received a positive response to its Letter of Intent (LOI) from the U.S. Food and Drug Administration (FDA) detailing the decision to accept the iBox Scoring System (Composite Biomarker Panel) into the Center for Drug Evaluation and Research (CDER) Biomarker Qualification Program (BQP).

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Submit Form Click here for more information about our products